+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urology Devices Market - Forecasts from 2021 to 2026

  • PDF Icon

    Report

  • 115 Pages
  • July 2021
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5397911
The global urology devices market is expected to grow at a compound annual growth rate of 9.33% over the forecast period to reach a market size of US$52.684 billion in 2026 from US$28.213 billion in 2019. Urology devices are clinical devices utilized for the analysis and treatment of kidney and urology infections. The arising pattern in urological surgeries is the inclination for utilization of negligibly obtrusive devices because of benefits like fewer cuts, quicker recuperation rate, and fewer medical clinic stays contrasted with open careful mediation. The present pattern in this market is the advancement and utilization of cutting-edge urology devices like laser and automated helped devices to make surgery considerably less complex with better results like more noteworthy exactness and precision, representation of mind-boggling careful destinations, and fast recovery.



Developing inclination for negligibly intrusive systems is required to be one of the major factors driving the development of the urology devices market. Throughout the long term, negligibly intrusive medical procedures (MIS) have gone through an uncommon change as far as innovative progressions, which has achieved a change in outlook in the way urological strategies are acted in working rooms. The benefits offered by negligibly obtrusive careful devices incorporate fewer scars, faster recuperation periods, more limited emergency clinic stays diminished blood misfortune and injury, a lower hazard of contamination, and decreased general medical care costs. In the urology field, MIS includes advanced mechanics, endoscopy, and laparoscopy to get to the urinary lot and related organs for a conclusion, treatment, and the executives of urological conditions. The most ordinarily utilized automated framework by urologists is the da Vinci mechanical medical procedure framework by Intuitive Surgical (US). This system utilizes a surgical console in which a surgeon controls instruments attached to mechanized arms, thus indicating the presence of constant innovation in the market, which is further expected to boost the urology devices market as well. Furthermore, taking note of the increasing demand for urology devices, companies operating in the market are undertaking various strategic actions to further increase their market share. For instance, in May 2021, Olympus Corporation, a Japanese manufacturer of optics and reprography products acquired Israeli Medical Device Company Medi-Tate. The move is said to be a strategic acquisition to expand Olympus Corporation’s BPH portfolio into in-office treatment.

Growth Factors.

  • Rising elderly population.

The consistently rising population of people above the age of 65 years is also expected to contribute to the urology devices market growth. According to the United Nations (UN) data of World Population Prospects for the year 2019 highlighted that the world’s population is expected to increase by two billion persons in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050, and with this, the world’s aging population is growing too. Due to increasing life expectancy and falling fertility levels, the UN explained that for the first time in history, individuals aged 65 or above outnumbered children under five years of age globally. Moreover, by 2050, one in six people in the world will be over the age of 65 (16%), up from one in 11 in 2019 (9%). Thus, with the increasing geriatric population, the demand for urology devices is also expected to increase, considering the increasing prevalence of kidney diseases in them.

Restraints.

  • Huge capital investment.

There is a serious level of rivalry among the market players. Just significant organizations can bear the cost of high-capital ventures just as the significant expense of R&D and assembling. This will keep new participants from entering this market. New participants in this market need to rival existing players and put themselves aside by creating imaginative item contributions. The serious level of combination goes about as a significant section boundary for new contestants, which thusly is relied upon to limit ventures and accordingly hinder the development capability of this market. The prerequisite of high-capital speculations and the significant expense of R&D and assembling will likewise prevent new players.

Impact of COVID – 19.

The COVID-19 pandemic has disrupted health systems worldwide. This has had a profound impact on urological care and urology care providers. The developing number of COVID-19 cases across the globe has immersed numerous medical services offices with fundamentally sick patients. The COVID-19 strain normally causes intense respiratory pain in patients and may bring about intense kidney injury and, now and again, kidney disappointment. As per the American Society of Nephrology, roughly 10−50% of patients with serious COVID-19 conceded to escalated care units have kidney disappointment that requires some type of dialysis. The developing instances of COVID-19-contaminated patients across the globe are expected to support the interest in dialysis strategies. Therefore, the interest in home dialysis machines has expanded attributable to the expanding inclination for home dialysis treatment because of movement limitations.

Competitive Insights.


The increasing demand for urology devices has led to the entry of several new market players like Stryker in the urology devices market. The entry of these new players in a market where traditional pharma behemoths like STERIS Corporation and Olympus Corporation already exist is expected to lead to further innovation in the urology devices market. Moreover, in order to further increase their clientele as well as increase their market share in the upcoming years, many of these market players have taken various strategic actions like partnerships and development of novel solutions which primarily focus on providing comfort to the patient, which is expected to keep the market competitive and constantly evolving.

Market Segmentation:


By Devices


  • Dialysis Devices
  • Endoscopic Devices
  • Lasers & Lithotripsy Devices
  • Endo vision Devices
  • Others

By Vessel Type


  • Prostate Cancer
  • Bladder Cancer
  • Kidney Stones
  • Benign Prostatic Hyperplasia
  • Others

By End-Users


  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Specialty Clinics

By Geography


  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Urology Devices Market Analysis, By Devices
5.1. Introduction
5.2. Dialysis Devices
5.3. Endoscopic Devices
5.4. Lasers & Lithotripsy Devices
5.5. Endo vision Devices
5.6. Others
6. Urology Devices Market Analysis, By Vessel Type
6.1. Introduction
6.2. Prostate Cancer
6.3. Bladder Cancer
6.4. Kidney Stones
6.5. Benign Prostatic Hyperplasia
6.6. Others
7. Urology Devices Market Analysis, By End-Users
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Ambulatory Care Centers
7.4. Specialty Clinics
8. Urology Devices Market Analysis, By Geography
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. UK
8.4.2. Germany
8.4.3. Italy
8.4.4. Spain
8.4.5. Others
8.5. The Middle East and Africa
8.5.1. Israel
8.5.2. Saudi Arabia
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. Australia
8.6.5. South Korea
8.6.6. Taiwan
8.6.7. Thailand
8.6.8. Indonesia
8.6.9. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles.
10.1. STERIS Corporation
10.2. Integer Holdings Corporation
10.3. Olympus Corporation
10.4. Siemens Medical Solutions
10.5. Boston Scientific Corporation
10.6. Surgical Holdings
10.7. Medtronic
10.8. Dornier MedTech
10.9. Stryker
10.10. Cook Medical

Companies Mentioned

  • STERIS Corporation
  • Integer Holdings Corporation
  • Olympus Corporation
  • Siemens Medical Solutions
  • Boston Scientific Corporation
  • Surgical Holdings
  • Medtronic
  • Dornier MedTech
  • Stryker
  • Cook Medical

Methodology

Loading
LOADING...

Table Information